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 30 
ABSTRACT 31 
The pathogenic fungus Cryptococcus enters the human host via inhalation into the lung and is able to 32 
reside in a niche environment that is serum (opsonin) limiting. Little is known about the mechanism by 33 
which non-opsonic phagocytosis occurs via phagocytes in such situations. Using a combination of 34 
soluble inhibitors of phagocytic receptors and macrophages derived from knockout mice and human 35 
volunteers, we show that uptake of non-opsonised Cryptococcus neoformans and Cryptocccous gattii 36 
via the mannose receptor is dependent on macrophage activation by cytokines. However, while uptake 37 
of C. neoformans is via both dectin-1 and dectin-2, C. gattii uptake occurs largely via dectin-1. 38 
Interestingly, dectin inhibitors also blocked phagocytosis of unopsonised Cryptococci in wax moth 39 
(Galleria mellonella) larvae and partially protected the larvae from infection by both fungi, supporting 40 
a key role for host phagocytes in augmenting early disease establishment. Finally, we demonstrated that 41 
internalisation of non-opsonised Cryptococci is not accompanied by the nuclear translocation of NFB 42 
or its concomitant production of proinflammatory cytokines such as TNF. Thus, non-opsonised 43 
Cryptococci are recognised by mammalian phagocytes in a manner that minimises proinflammatory 44 






























Cryptococcus neoformans and Cryptococcus gattii are encapsulated human fungal pathogens that cause 51 
cryptococcosis in immunocompromised and, more rarely, immunocompetent individuals. Often found 52 
as free-living cells in soil and avian excreta, Cryptococci are not intrinsic human pathogens. However, 53 
Cryptococci become human pathogens because several defence mechanisms possessed by these fungi 54 
also act as virulence factors within a human or animal host (1), including the ability firstly, to survive 55 
and replicate within free-living soil amoeba and, secondly to evade clearance by the host immune 56 
system by hiding and persisting within macrophages (2, 3). 57 
As Cryptococci enter hosts via inhalation into the lungs, they are detected and phagocytosed by 58 
resident alveolar macrophages (4). Phagocytosis is a multi-step process that sequentially involves 59 
receptor-mediated particle recognition, actin-driven uptake, phagosome maturation and particle 60 
clearance. It is critical during the early innate immune response to ensure the removal of 61 
microorganisms and apoptotic cells as well as subsequent priming of the adaptive immune response 62 
through the production and release of cytokines, such as Tumour Necrosis Factor- (TNF-) (5). 63 
Phagocytosis of Cryptococci is typically inefficient unless they are opsonised (coated) by antibodies or 64 
complement proteins found in serum within the circulatory system.  Interestingly, there is a lack of 65 
serum opsonins in the alveoli of the lungs, and so the initial uptake of Cryptococcus upon colonisation 66 
is most likely through a non-opsonised route (6). 67 
Non-opsonic phagocytosis requires host cell phagocytic pattern recognition receptors (PRRs) to 68 
directly recognise fungal cell wall components (pathogen associated molecular patterns; PAMPs) (7) 69 
such as β-glucans or mannan polysaccharides, but the nature of this interaction for Cryptococci remains 70 
unknown.  Here we show that non-opsonised C. neoformans and C. gattii enter macrophages in a Syk-71 
dependent, mannose receptor-independent manner that involves the receptors Dectin-1 and Dectin-2. 72 
This differential uptake of C. neoformans and C. gattii corresponds to differential exposure of PAMPs 73 

























absence or presence of cellular receptor inhibitors were similar in response to fungal targets. Finally, 75 
we demonstrate that entry of Cryptococcus does not affect NFB nuclear translocation or subsequent 76 














































MATERIALS AND METHODS 99 
Reagents  100 
All reagents (e.g. heat-inactivated fetal bovine serum, FBS; Dulbecco’s Modified Eagle’s Medium 101 
(DMEM); L-glutamine; powdered yeast-extract peptone dextrose, YPD and phosphate buffered saline, 102 
PBS) were purchased from Sigma unless stated otherwise. Mouse macrophage- and Human 103 
granulocyte-macrophage- colony stimulating factors (mM-CSF, 130-094-129 and hGM-CSF, 130-093-104 
862) were purchased from Miltenyi Biotec. Commercially sourced inhibitors tested included the Syk 105 
inhibiting plant metabolite, Piceatannol (527948, Calbiochem), the β-1,3-glucan from brown algae 106 
Laminaria digitata, Laminarin (L9634, Sigma) and mannan from Saccharomyces cerevisiae (M7504, 107 
Sigma). 108 
The antibodies used in this study were rabbit anti-sheep red blood cells, IgG fraction (#55806, MP 109 
Biomedicals), rabbit anti-sheep red blood cells, IgM fraction (CL9000M, VH Bio/Cedarlane), rabbit 110 
anti-p65 NFkB monoclonal antibody (clone D14E12, #8242, NEB/Cell Signalling), rat anti-M (clone 111 
5c6, MCA2289, Bio-Rad/AbD Serotec), rabbit anti-Phospho-Syk (Tyr525/526 in humans, Tyr519/520 112 
in mice, clone C87C1, #2710, NEB/Cell Signalling, a kind gift from Yotis Senis, University of 113 
Birmingham). Rhodamine-Phalloidin and Alexa Fluor conjugated secondary antibodies were purchased 114 
from Life Technologies and Calcofluor White from Sigma. Glucan-6-phosphate and mouse anti-115 
cryptococcal capsule antibody (clone 18B7) were kind gifts from David Williams (East Tennessee 116 
State University) and Arturo Casadevall (Albert Einstein College of Medicine) respectively.  117 
 118 
Mice 119 
Mice devoid of specific PRRs (in C57BL/6 background) were published before (8, 9) and were housed 120 
under pathogen-free conditions in the registered animal facility at the University of Aberdeen. Mice 121 
were allocated to experimental groups on the basis of genotype and age-matching. All animal 122 

























Review Body (AWERB) of the University of Aberdeen and is regulated by the UK Home Office’s 124 
Animal (Scientific Procedures) Act of 1986 and European Directive 2010/63/EU. 125 
 126 
Yeast and bacterial cell growth conditions 127 
C. neoformans strain H99, C. gattii strain R265, Candida albicans strains SC5314 were incubated in 128 
liquid YPD medium for 24hr (unless stated otherwise) at 25
o
C on a rotator at 20rev/min (or 37
o
C, 200 129 
rpm for C. albicans). Escherichia coli strain DH5 was incubated in Luria-Bertani broth for 16hr at 130 
37
o
C in a shaking incubator at 200rpm. Yeast cells were centrifuged at 3000g for 2.5min (or 6000g for 131 
1min for E. coli), washed three times in PBS and counted with a haemocytometer prior to use. 132 
 133 
Mammalian cell growth conditions 134 
Cells from the murine macrophage-like cell line J774.A1 (American Type Culture Collection number 135 
TIB-67) were cultured in DMEM supplemented with 2mM L-glutamine and 10% heat-inactivated FBS 136 
at 37
o
C, 5% CO2 (10). As required, macrophages were scrapped in PBS, counted and seeded (50 000 137 
per well) onto 13mm acid-washed glass coverslips and incubated for 24hr at 37°C, 5% CO2 – prior to 138 
experimental use.  139 
Macrophages devoid of specific PRRs were derived from mouse bone marrow. Bone marrows were 140 
flushed using a 21-gauge needle from the hind leg bones of either receptor knockout or litter-matched 141 
wild type mice. Monocytes were differentiated into macrophages with 20ng/ml macrophage-colony 142 
stimulating factor (M-CSF, Miltenyi Biotec) for 7 days.   143 
Pooled peripheral blood mononuclear cells (PBMC) were isolated from whole blood from healthy 144 
volunteers using density gradient centrifugation with Ficoll-Paque (GE Healthcare). The mononuclear 145 
layer was collected and washed with PBS to remove platelets. Monocytes were purified by adherence 146 
to plastic in RPMI-1640 media supplemented with 5% heat-inactivated FBS, 2mM glutamine, 147 
100mg/ml streptomycin, 100units/ml penicillin at 37
o

























removed with PBS and adherent cells differentiated into macrophages with 20ng/ml recombinant 149 
human granulocyte macrophage-colony stimulating factor (rhGM-CSF, Miltenyi Biotec) for 7 days. 150 
This study was covered by the University of Birmingham’s Science, Technology, Engineering and 151 
Mathematics Ethical Review Committee. 152 
 153 
Phagocytic challenge 154 
Macrophages were serum starved for 2 – 16hr with serum-free medium at 37
o
C, 5% CO2. Where 155 
needed, inhibitors were added directly and left for a further 30min. Next, media was removed prior to 156 
fresh serum-free medium added containing either 1g/ml 18B7 antibody (against cryptococcal capsule) 157 
or unopsonised targets at a multiplicity of infection (MOI) of either 10:1 or 20:1 for 20-180min at 158 
37°C, 5% CO2. Cells were washed three times with PBS to remove unbound yeast/bacteria cells and 159 
fixed in 4% paraformaldehyde for 10min at room temperature.  160 
 161 
Galleria mellonella maintenance 162 
Larvae of the greater wax moth, G. mellonella, were sourced from Livefoods Direct (UK) and stored in 163 
wood shavings in the dark at 13
o
C. This study was covered by the University of Stirling’s Animal, 164 
Welfare and Ethical Review Body (AWERB). Healthy larvae weighing between 0.2 and 0.4 g were 165 
used in all experiments. Larvae were inoculated with different concentrations of inhibitors via 166 
intrahaemocoel injection 1hr prior to infection with 1 million C. neoformans H99 per larva as described 167 
previously (11). Controls consisted of larvae that received a 20l PBS inoculum. 3-5 larvae were used 168 
per treatment, with all treatments being performed on at least three independent occasions. 169 
For phagocytosis, larvae were bled and haemolymph treated as previously described (12). Briefly, 170 
pooled haemolymph was mixed with 0.5ml PBS and added onto a 13mm coverslip in a 24-well plate. 171 

























before washing 3 times with PBS to remove non-internalised yeasts. Cells were then fixed with 4% 173 
paraformaldehyde before permeabilisation and immunostained as described below. All determinations 174 
were performed on at least three independent occasions.  175 
 176 
Immunofluorescence and scoring  177 
Fixed cells on coverslips were permeabilised with 0.1% Triton-X-100 for 5 min (if necessary to 178 
identify internalised yeasts), washed with PBS and blocked with 0.5% bovine serum albumin (BSA) in 179 
PBS for 30 min. Appropriate primary antibodies (1:200 dilution) were added to cells, left for 30 min at 180 
room temperature, washed with PBS, and counter stained with the appropriate fluorophore-conjugated 181 
secondary antibody, along with Rhodamine-Phalloidin and Calcofluor White. Coverslips were then 182 
washed in PBS and distilled water before mounted in ProLong Gold antifade reagent (Life 183 
Technologies) and analysed by microscopy. 184 
For counting of phagocytosed yeast/bacteria, fixed but unpermeabilised cells on coverslips were 185 
stained with Calcofluor White to highlight the external yeasts. Coverslips were analysed with a Nikon 186 
Eclipse Ti microscope under a 63x oil immersion objective. Between 5 – 10 fields of view of each 187 
coverslip were counted for number of macrophages and association of microbial cells. At least 100 188 
macrophages were observed for each cover-slip.   189 
The enrichment in phosphorylated Syk at sites of yeast binding and the translocation of p65 into the 190 
nucleus during NFB activation were studied and scored by the Nikon A1R confocal microscope using 191 
20x – 63x objectives. For the former, a minimum of 25 infected cells per condition were analysed for a 192 
discrete local enrichment in marker signal (Syk) at bound particles. For the latter, between 3-5 fields of 193 
view for each sample/coverslip were counted for the number of macrophages with p65 marker signal 194 
located within the nucleus and expressed as a percentage of the total number of macrophages (%NFB 195 


























In vitro cytokine production 198 
J774.A1 and primary human macrophages were cultured in 96-well microtiter plates (Greiner) at 10000 199 
cells/well, in a final volume of 200l. Cells were stimulated with either control medium or LPS or a 200 
range of unopsonised pathogenic yeasts. After 6hr of incubation at 37
o
C, plates were centrifuged (500g 201 
for 10min), and the supernatant was collected and stored at -80
o
C until cytokine assays were 202 
performed. Levels of TNF- were determined by commercial ELISA kits, used according to the 203 
instructions of the manufacturer (R&D Systems). 204 
 205 
Statistical analyses 206 
Analysis carried out on the results described in this paper was by a generalise linear model (GLM) 207 
using a Poisson error distribution in R (R Development Core Team). This was tested for significance 208 
using a Posthoc Tukey Honesty Significant Difference (HSD) test.  209 
 210 
RESULTS 211 
Uptake of non-opsonised Cryptococci via mannose receptor is activation dependent 212 
As previously observed, the levels of non-opsonic uptake of Cryptococci is very low (e.g. 0.4% of C. 213 
neoformans serotype D was taken up by unstimulated mouse peritoneal macrophages; or 7-21% of C. 214 
gattii R265 was taken up by human dendritic cells; 13, 14) and our results are in agreement with those 215 
findings – 8.89% or 5.83% of primary human macrophages contained one or more C. neoformans H99, 216 
or C. gatii R265, respectively (based on the carrier controls in Figures 1C and 2B) after two hours of 217 
incubation. The mannose receptor is broadly expressed on macrophages and important for the non-218 
opsonic uptake of fungal pathogens such as Candida albicans and Pneumocystis carinii (15, 16).  The 219 

























mannan (a competitive inhibitor of mannose receptor binding) was unaltered relative to control 221 
(untreated) cells (Figure 1A). Similarly, M-CSF differentiated bone marrow macrophages from 222 
mannose receptor knock-out mice (MR KO) showed no reduction in uptake of either Cryptococcus 223 
neoformans (Cn) or Cryptococcus gattii (Cg) relative to wildtype control cells (Figure 1B). 224 
Interestingly, however, GM-CSF differentiated primary human macrophages showed a strong 225 
inhibition of uptake under the same conditions (Figure 1C), suggesting that the mannose receptor may 226 
play a greater role in cryptococcal uptake into human cells than those of mice. 227 
 228 
Phagocytosis of unopsonised Cryptococci is Syk-dependent  229 
The other major class of non-opsonic phagocytic receptors for fungi are the dectins (17). Both dectin-1 230 
and dectin-2 require Syk activity for their function, via immunoreceptor tyrosine-based activation 231 
motifs (ITAM) contained within dectin-1 itself or via membrane association with ITAM-containing Fc 232 
receptor  chain in the case of dectin-2 (18). Inhibiting Syk activity in J774.A1 cells by using 233 
piceatannol (19) resulted in a marked reduction in their ability to phagocytose either C. neoformans 234 
H99 or C. gattii R265 (Figure 2A, p<0.05). The same observation was also seen in GM-CSF 235 
differentiated primary human macrophages from pooled monocytes isolated from human volunteers 236 
(Figure 2B). In line with this, staining with an anti-Phospho-Syk antibody showed intense 237 
accumulation of active Syk at phagocytic cups forming around non-opsonised Cryptococci (Figure 3). 238 
This antibody was raised against the tyrosine phosphorylated residues at positions 525 and 526, located 239 
in the activation loop of the Syk kinase domain and essential for Syk function (20). Therefore, we 240 
propose that the localisation of this antibody to the sites of non-opsonic uptake of Cryptococci and the 241 
activity of piceatannol in blocking uptake suggests that Syk activity is required for internalisation.  242 
 243 

























To test for a role for the dectin family of receptors during phagocytic uptake of non-opsonised 245 
Cryptococci, we first exposed J774.A1 macrophages (Figure 4A) or differentiated primary human 246 
macrophages (Figure 4B) to the dectin-1 inhibitor glucan-6-phosphate before challenging with either 247 
unopsonised C. gattii R265 or C. neoformans H99. This inhibitor partially blocked the uptake of both 248 
species of Cryptococcus, suggesting dectin-1 contributes towards Cryptococci uptake but is not the sole 249 
recognition receptor involved in this process (Figures 4A and 4B).  In line with this, M-CSF-250 
differentiated bone marrow macrophages (BMM) from dectin-1 and dectin-2 knockout mice both 251 
showed substantially impaired uptake of C. neoformans H99 – surprisingly, this was not the case for C. 252 
gattii R265 (Figure 4C). This suggests either the presence of another Syk-dependent non-opsonic 253 
receptor, or that both dectins are redundant with each other for C. gattii, but not C. neoformans uptake. 254 
 255 
Non-opsonic uptake in the Galleria model 256 
The greater wax moth, Galleria mellonella, is widely used as a model organism in the study of host-257 
pathogen interactions with a variety of human pathogens (21). As with other insects, G. mellonella does 258 
not possess an adaptive immune system like mammals but possesses a complex innate immune system 259 
that includes phagocytic cells, termed haemocytes (22, 23). We therefore tested whether non-opsonic 260 
uptake of Cryptococci in G. mellonella showed similar receptor dependency as in mammalian cells by 261 
pre-treating larvae for 1hr with soluble mannan or glucan-6-phosphate or laminarin. The full genome 262 
sequence of Galleria is currently available though not fully annotated (24). However, several β-1,3-263 
glucan binding protein analogues and C-type lectins have been characterised in this species, as well as 264 
other Lepidopterans, namely Manduca sexta (25, 26), Bombyx mori (27) and Plodia interpunctella 265 
(28). Recognition of fungal PAMPs (e.g. curdlan and mannan) by membrane bound receptors modulate 266 
cellular (haemocyte)-directed immunity in insects (encapsulation, nodulation and phagocytosis) (29).  267 

























haemocytes in data presented here, both glucan-6-phosphate and laminarin led to a marked reduction in 269 
uptake (Figure 5, p<0.001 for both when compared to the PBS controls).  270 
Interestingly, administering glucan-6-phosphate or laminarin for 24 h appeared to partially protect the 271 
insect larvae from infection by both unopsonised species of Cryptococcus (Figure 6) suggesting that 272 
disease establishment in this model organism requires the fungus to grow intracellularly, something 273 
that has previously been proposed for human hosts (30). 274 
 275 
Cryptococcal uptake by macrophages does not lead to increased proinflammatory cytokine 276 
secretion  277 
Unlike many pathogens, internalisation of opsonised Cryptococci into phagocytes is not accompanied 278 
by the production of proinflammatory cytokines such as tumor necrosis factor (TNF) and interleukin 279 
(IL)-1 or IL-1 (31, 32). To test whether this is also true of non-opsonic uptake, we measured the 280 
secretion of TNF and nuclear translocation of p65 (a major regulator of cytokine transcription) from 281 
J774.A1 macrophages upon challenge with unopsonised or serum-opsonised C. neoformans H99 or C. 282 
gattii R265. Although LPS-stimulated macrophages showed strong nuclear translocation of p65, 283 
neither IgG-opsonised nor unopsonised C. neoformans H99 or C. gattii R265 stimulated NFB 284 
activation (Figure 7A).  However, NFB activation could be restored in cryptococcal exposed 285 
macrophages by the subsequent addition of LPS (Figure 7B).   286 
Furthermore, to test whether internalisation of unopsonised Cryptococci into J774.A1 mouse 287 
macrophages or primary human macrophages elicits the production of proinflammatory cytokines such 288 
as tumor necrosis factor (TNF), we measured the secretion of TNF from J774.A1 macrophages or 289 
primary human macrophages upon challenge with unopsonised C. neoformans H99 or C. gattii R265, 290 
with Candida albicans and LPS as controls.  With J774.A1 mouse macrophage and primary human 291 

























compared to varying doses of C. neoformans H99 or C. gattii R265 (Figure 8; p = 0.04 for Ca vs. 293 
media control, p > 0.05 for Ca vs. Cn/Cg). Overall this suggests that Cryptococci do not actively block 294 
inflammatory signalling in host cells, and do not induce a strong inflammatory stimulus following non-295 
opsonic uptake. 296 
 297 
DISCUSSION 298 
In this study, we examined the phagocytic uptake of unopsonised cryptococcal yeast particles by 299 
macrophages. This process relies on the use of phagocytic receptors, which can be categorised either as 300 
opsonic or non-opsonic. Opsonic phagocytic receptors include the Fc receptor and complement 301 
receptor families, which recognises antibody- or complement- opsonised (coated) particles, 302 
respectively. Non-opsonic phagocytic receptors are pattern recognition receptors (PRRs), such as the 303 
C-type lectin family of receptors recognizes distinct pathogen-associated molecular patterns (PAMPs) 304 
on the fungal surface (33).  305 
While phagocytosis of Cryptococcus within the circulatory system would occur predominantly through 306 
an opsonised (coated) uptake route due to the presence of antibodies and/or complement proteins found 307 
in serum, this is not always the case. For example, first encounter of the human body with 308 
Cryptococcus is through the lungs when desiccated yeast cells or spores are breathed in. These 309 
cryptococcal particles encounter their initial immunological challenge through resident alveolar 310 
macrophages and dendritic cells in a serum-deficient or low-serum environment (34, 35, 36). 311 
Interestingly, it was reported recently that between 25-40% of mouse lung-resident macrophages are 312 
able to phagocytose C. neoformans particles through a scavenger receptor pathway (37). Therefore, this 313 
confirms that initial uptake of Cryptococcus by macrophages is most likely through a non-opsonised 314 
route and there is a need to understand the mechanisms that underpins this process (6). We confirmed 315 
that, compared to the bacterium Escherichia coli or fungus Candida albicans, Cryptococci cells are not 316 

























renders Cryptococci anti-phagocytic (38, 39).  By using a combination of a soluble mannose inhibitor 318 
and mannose receptor knockout mouse tissue, we demonstrated that mannose receptor was not 319 
necessary for the uptake of either species of Cryptococcus, in line with recent data from the zebrafish 320 
model (40), though this is not the case in primary human macrophages. We note that others have shown 321 
mannose receptor knockout mice to be more susceptible to C. neoformans (41) and demonstrated a role 322 
for this receptor, along with FcRII (CD32) in driving cryptococcal uptake into dendritic cells (42). 323 
Thus, mannose receptor dependency apparently varies across different cell types and tissue contexts.  324 
Next, we pursued a different set of non-opsonic pattern recognition receptors, dectin-1 and dectin-2 325 
which are C-type lectin receptors (CLRs) that are highly expressed in macrophages and are key -326 
glucan receptors (43, 44). Recognition of soluble or surface expressed β-glucans on yeasts is sufficient 327 
to initiate and mediate phagocytosis and pro-inflammatory cytokine responses (45). Both of these 328 
receptors require Syk activity (46, 47, 18) and indeed our data clearly demonstrate the activation of Syk 329 
at phagocytic cups containing unopsonised Cryptococci, as well as a strong dependency on Syk for 330 
particle uptake. Interestingly, pharmacological inhibition of dectins inhibited uptake of both C. 331 
neoformans and C. gattii in J774.A1 mouse and human macrophages, but bone marrow macrophages 332 
(BMM) from dectin-1- and dectin-2- knockout mice showed defects only in the uptake of C. 333 
neoformans and not C. gattii, an effect that has been observed before (48).  The most parsimonious 334 
explanation is therefore that the two dectin receptors are redundant for the uptake of C. gattii, but not 335 
C. neoformans, perhaps reflecting differing the surface components between the two species as 336 
reported recently (49). Such surface variation between species, strains and potentially developmental 337 
stages of Cryptococci may explain many of the previous inconsistencies in the literature regarding 338 
dectin dependency (or otherwise) (50, 51).  339 
Alongside mouse macrophages, we adopted wax worm larvae (Galleria mellonella) as an alternative 340 

























cryptococcal phagocytosis has previously been reported (55). Our data demonstrate striking similarities 342 
in patterns of uptake between this invertebrate host and murine phagocytes.  In addition, we showed 343 
that inhibiting phagocytosis in this alternative host reduces disease burden, highlighting the importance 344 
of host phagocytes as a niche for cryptococcal replication. 345 
We acknowledge that while there are currently no direct dectin receptor homologues identified in G. 346 
mellonella, many C-type lectins have been characterised in other insect models, for example the 347 
tobacco hornworm, Manduca sexta (immulectin-2 facilitates phagocytosis of bacteria; 56), webworm, 348 
Hyphantria cunea (lectin; 57, 58) silkworm, Bombyx mori (BmLBP and BmMBP; 59, 60) and the 349 
cockroach, Blaberus discoidalis (a β-glucan-specific lectin; 61). These invertebrate C-type lectins show 350 
up to 35% similarity with mammalian C-type lectins and can bind to several PAMPs, including LPS, 351 
LTA and -glucan and are inducible when the host is exposed to microbial challenge or ligands and the 352 
mechanisms for uptake of pathogenic microbes by G. mellonella hemocytes are similar to that of 353 
human neutrophils (62).   354 
Two key reports have shown that there are at least 3 scavenger receptors involved in the recognition of 355 
different serotypes of Cryptococcus neoformans, namely the homologous genes from the nematode 356 
Caenorhabditis elegans, CED-1 and C03F11.3 as well as the mouse MARCO scavenger receptors (37, 357 
63). Interestingly, knocking out MARCO gene from mice did not abolish uptake of Cryptococcus 358 
neoformans by lung-resident mononuclear phagocytes (37), suggesting role(s) for the extent and 359 
distribution of multiple receptors and ligands on the surface of both host cell and yeast. 360 
Finally, we demonstrate that entry of Cryptococcus does not affect NFB nuclear translocation and its 361 
subsequent TNF- release in the Dectin-1/Syk/NFB signalling axis – both in J774.A1 mouse 362 
macrophages and in primary human macrophages.  Although it is known that Dectin-1 coupling to Syk 363 

























including expression of proinflammatory cytokines such as TNF- (64-66), this appears not to be the 365 
case for cryptococcal uptake.  366 
In conclusion, we propose that unopsonised Cryptococci are recognised and engulfed via mannose 367 
receptor- or dectin-based recognition in vitro depending on the activation state of the host cells. The 368 
absence of an associated pro-inflammatory cascade allows the yeast to exploit this intracellular niche 369 
for rapid disease establishment.  370 
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 566 
FIGURE LEGENDS 567 
FIGURE 1. Mannose receptor is important but dispensable during uptake of Cryptococcus particles. 568 
Mouse macrophage cell line J774.A1 (A) or differentiated bone marrow macrophages (B, wildtype, 569 
WT or mannose receptor knock out, MR KO) or differentiated primary human macrophages (C) were 570 
challenged with either Cryptococcus neoformans H99 (Cn, black bars) or Cryptococcus gattii R265 571 
(Cg, white bars) for 60min, processed for immunofluorescence and scored for phagocytosis as 572 
described in Materials and Methods. Where indicated, J774.A1 and primary human macrophages were 573 
pretreated with 100g/ml mannan (MAN) for 30min before the addition of Cryptococcus particles. 574 
Phagocytosis indices were related to the values obtained from the negative controls. Number in bars 575 
indicate the total number of phagocytes counted. Results are expressed as the mean± SD of at least 576 
three independent experiments. 577 
 578 
FIGURE  2: Uptake of Cryptococcus particles is Syk dependent. Mouse macrophage cell line J774.A1 579 
(A) or differentiated primary human macrophages (B) were challenged with unopsonised Cryptococcus 580 
neoformans H99 (Cn, black bars) or Cryptococcus gattii R265 (Cg, white bars) for 60 min, processed 581 
for immunofluorescence and scored for phagocytosis as described in Materials and Methods. 582 

























indicate the total number of phagocytes counted. Results are expressed as the mean± SD of at least 584 
three independent experiments. 585 
 586 
FIGURE 3. Activated Syk is essential for the uptake of Cryptococcus particles. Mouse macrophage 587 
cell line J774.A1 was challenged with either (IgG-opsonised or unopsonised, U/O) Cryptococcus 588 
neoformans H99 or Cryptococcus gattii R265 for 15min (B), processed for immunofluorescence and 589 
analysed by confocal microscopy of localised phospho-Syk (B, C) as described in Materials and 590 
Methods. (A) Schematic diagram J774.A1 macrophage with intracellular actin cytoskeleton (red) and 591 
yeast particles (blue). To confirm phospho-Syk localisation, the bottom of the cells was observed first 592 
(A, green dash line and B, bottom panels), before moving to the middle of the cells (A, purple dash 593 
line, B, top panels). Pixel intensities for 20 cells per sample were determined (C, right) and normalised 594 
to the intensity at the centre of the cell (C, left). Results are expressed as the mean± SD of at least three 595 
independent experiments. 596 
 597 
FIGURE 4. Dectins are required for uptake of Cryptococcus particles. Mouse macrophage cell line 598 
J774.A1 (A), differentiated primary human macrophages (B) or differentiated bone marrow 599 
macrophages (C, wildtype, WT or Dectin-1 or Dectin-2 knockout, KO) were challenged with either 600 
Cryptococcus neoformans H99 (Cn, black bars) or Cryptococcus gattii R265 (Cg, white bars) for 60 601 
min, processed for immunofluorescence and scored for phagocytosis as described in Materials and 602 
Methods. Where indicated, J774.A1 were pretreated with 100g/ml glucan-6-phosphate (G6P) for 603 
30min before the addition of Cryptococcus particles. Phagocytosis indices were related to the values 604 
obtained from the negative controls. Number in bars indicate the total number of phagocytes counted. 605 
Results are expressed as the mean± SD of at least three independent experiments. ns, not significant, p 606 


























FIGURE 5. Administration of polysaccharides blocks uptake of Cryptococcus particles to hemocytes 609 
in the Galleria mellonella larvae model. Larvae were inoculated with 60g of blocking sugars 1hr 610 
prior to infection for 2hr with 10
6
 Cryptococcus neoformans H99 (black bars) or Cryptococcus gattii 611 
R265 (white bars). Uptake of yeast of hemocytes was determined under light microscopy. Results are 612 
expressed as the mean± SD of at least three independent experiments. ns, not significant, p ≥ 0.05; *, p 613 
< 0.05 (related to PBS control) 614 
 615 
FIGURE 6. Glucan administration protects Galleria mellonella larvae from infection by Cryptococcus 616 
neoformans or Cryptococcus gattii. Larvae were inoculated with 60g of blocking sugars 24hr prior to 617 
infection for further 24hr with 10
6
 Cryptococcus neoformans H99 (black bars) or Cryptococcus gattii 618 
R265 (white bars). Fungal load was determined by serially diluting homogenized larvae and plating 619 
aliquots onto erythromycin containing agar plates. Yeast cell density were related to the values 620 
obtained from the negative (PBS) controls and expres ed as cfu *10
5
/larva. Results are expressed as the 621 
mean ± SD of at least three independent experiments. ns, not significant, p ≥ 0.05; *, p < 0.05 (related 622 
to PBS control) 623 
 624 
FIGURE 7. Uptake of Cryptococcus did not affect NFB nuclear translocation. J774.A1 macrophages 625 
were challenged with a variety of opsonised or unopsonised pathogenic fungi or sheep red blood cells 626 
(SRBC) or soluble agonists (LPS or PMA), processed for immunofluorescences and analysed by 627 
microscopy (A) and scored for p65 nuclear translocation (B), as described in Materials and Methods. 628 
(A) Representative images of PMA- (top) or LPS- (bottom) stimulated J774.A1 macrophages and 629 


























FIGURE 8. Uptake of Cryptococcus did not affect proinflammatory cytokine response. J774.A1 632 
macrophages (black bars) or differentiated primary human macrophages (white bars) were challenged 633 
with a variety of unopsonised pathogenic fungi (Cryptococcus neoformans, Cn; Cryptococcus gattii. 634 
Cg; Candida albicans, Ca) or LPS and subsequent supernatants were analysed by ELISA, as described 635 
in Materials and Methods. Results are expressed as the mean ± SD of at least three independent 636 
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